# HIVE Digital Technologies Ltd.: financial statements, quarterly

HIVE · Nasdaq · CIK 1720424 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/hive.md) · [Financials](/companies/hive/financials.md) · [Filings](/companies/hive/filings.md) · [Insiders](/companies/hive/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hive/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-06-30) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: |
| Revenue | $m | [45.6](/filings/0001062993-26-004434.md) | [79.1](/filings/0001062993-26-004434.md) |
| Gross profit | $m | [(6.2)](/filings/0001062993-26-004434.md) | [(29.5)](/filings/0001062993-26-004434.md) |
| Selling, general and administrative | $m | [5.8](/filings/0001062993-26-004434.md) | [9.0](/filings/0001062993-26-004434.md) |
| Interest expense | $m | [0.1](/filings/0001062993-26-004434.md) | [0.4](/filings/0001062993-26-004434.md) |
| Income tax | $m | [0.6](/filings/0001062993-26-004434.md) | [1.6](/filings/0001062993-26-004434.md) |
| Net income | $m | [35.0](/filings/0001062993-26-004434.md) | [(143)](/filings/0001062993-26-004434.md) |
| Diluted EPS | $ per share | [0.18](/filings/0001062993-26-004434.md) | [(0.54)](/filings/0001062993-26-004434.md) |
| Basic EPS | $ per share | [0.19](/filings/0001062993-26-004434.md) | [(0.54)](/filings/0001062993-26-004434.md) |

- Revenue: us-gaap:Revenues
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2019-03-31) | period not labelled (2020-03-31) | FY2021 (2021-03-31) | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | period not labelled (2025-06-30) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.8](/filings/0001062993-21-009809.md) | [5.1](/filings/0001062993-22-016645.md) | [40.3](/filings/0001062993-23-014191.md) | [5.3](/filings/0001062993-24-012996.md) | [4.4](/filings/0001062993-24-012996.md) | [9.7](/filings/0001062993-25-012159.md) | [23.4](/filings/0001062993-26-002973.md) | not reported | [23.1](/filings/0001062993-26-004434.md) | [208](/filings/0001062993-26-004434.md) |
| Current assets | $m | not reported | [18.3](/filings/0001062993-21-009809.md) | [108](/filings/0001062993-22-016645.md) | [199](/filings/0001062993-23-014191.md) | [82.5](/filings/0001062993-24-012996.md) | [185](/filings/0001062993-25-012159.md) | [242](/filings/0001062993-26-002973.md) | not reported | [59.8](/filings/0001062993-26-004434.md) | [280](/filings/0001062993-26-004434.md) |
| Total assets | $m | not reported | [29.1](/filings/0001062993-21-009809.md) | [178](/filings/0001062993-22-016645.md) | [452](/filings/0001062993-23-014191.md) | [196](/filings/0001062993-24-012996.md) | [307](/filings/0001062993-25-012159.md) | [532](/filings/0001062993-26-002973.md) | not reported | [639](/filings/0001062993-26-004434.md) | [925](/filings/0001062993-26-004434.md) |
| Current liabilities | $m | not reported | [7.2](/filings/0001062993-21-009809.md) | [9.9](/filings/0001062993-22-016645.md) | [26.2](/filings/0001062993-23-014191.md) | [23.1](/filings/0001062993-24-012996.md) | [27.1](/filings/0001062993-25-012159.md) | [66.0](/filings/0001062993-26-002973.md) | not reported | [54.4](/filings/0001062993-26-004434.md) | [143](/filings/0001062993-26-004434.md) |
| Total liabilities | $m | not reported | [8.0](/filings/0001062993-21-009809.md) | [50.2](/filings/0001062993-22-016645.md) | [63.2](/filings/0001062993-23-014191.md) | [47.3](/filings/0001062993-24-012996.md) | [47.3](/filings/0001062993-25-012159.md) | [82.5](/filings/0001062993-26-002973.md) | not reported | [110](/filings/0001062993-26-004434.md) | [502](/filings/0001062993-26-004434.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [5.6](/filings/0001062993-25-012159.md) | [3.6](/filings/0001062993-26-002973.md) | not reported | [2.0](/filings/0001062993-26-004434.md) | [1.6](/filings/0001062993-26-004434.md) |
| Shareholders' equity | $m | [21.9](/filings/0001062993-21-009809.md) | [21.1](/filings/0001062993-22-016645.md) | [128](/filings/0001062993-23-014191.md) | [389](/filings/0001062993-24-012996.md) | [148](/filings/0001062993-26-002973.md) | [259](/filings/0001062993-26-002973.md) | [449](/filings/0001062993-26-004434.md) | [561](/filings/0001062993-26-004434.md) | [529](/filings/0001062993-26-004434.md) | [423](/filings/0001062993-26-004434.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents, us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: ifrs-full:CurrentAssets, us-gaap:AssetsCurrent
- Total assets: ifrs-full:Assets, us-gaap:Assets
- Current liabilities: ifrs-full:CurrentLiabilities, us-gaap:LiabilitiesCurrent
- Total liabilities: ifrs-full:Liabilities, us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: ifrs-full:Equity, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-06-30) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: |
| Operating cash flow | $m | [10.2](/filings/0001062993-26-004434.md) | [4.1](/filings/0001062993-26-004434.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2025-06-30) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [193](/filings/0001062993-26-004434.md) | [266](/filings/0001062993-26-004434.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 274,277,338 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001062993-26-004434.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.